Continuing medical education
Cutaneous manifestations of gastrointestinal disease: Part II

https://doi.org/10.1016/j.jaad.2012.10.036Get rights and content

The gastrointestinal (GI) and cutaneous organ systems are closely linked. In part I of this continuing medical education article, the intricacies of this relationship were explored as they pertained to hereditary polyposis disorders, hamartomatous disorders, and paraneoplastic disease. Part II focuses on the cutaneous system's links to inflammatory bowel disease and vascular disorders. An in-depth analysis of inflammatory bowel disease skin findings is provided to aid dermatologists in recognizing and facilitating early consultation and intervention by gastroenterologists. Cutaneous signs of inflammatory bowel disease include fissures and fistulae, erythema nodosum, pyoderma gangrenosum, pyostomatitis vegetans, oral aphthous ulcers, cutaneous polyarteritis nodosa, necrotizing vasculitis, and epidermolysis bullosa acquisita. Additional immune-mediated conditions, such as diverticulitis, bowel-associated dermatosis-arthritis syndrome, Henoch–Schönlein purpura, dermatitis herpetiformis, and Degos disease, in which the skin and GI system are mutually involved, will also be discussed. Genodermatoses common to both the GI tract and the skin include Hermansky–Pudlak syndrome, pseudoxanthoma elasticum, Ehlers–Danlos syndrome, hereditary hemorrhagic telangiectasia, and blue rubber bleb nevus syndrome. Kaposi sarcoma is a neoplastic disease with lesions involving both the skin and the gastrointestinal tract. Acrodermatitis enteropathica, a condition of zinc deficiency, likewise affects both the GI and dermatologic systems. These conditions are reviewed with updates on the genetic basis, diagnostic and screening modalities, and therapeutic options. Finally, GI complications associated with vascular disorders will also be discussed.

Section snippets

Ulcerative colitis and Crohn's disease

Key points

  1. The skin manifestations of Crohn's disease and ulcerative colitis (inflammatory bowel disease) show both similarities and differences, reflecting their respective pathophysiologies

  2. The prevalence of cutaneous manifestations is roughly equal for Crohn's disease and ulcerative colitis (9%-19% and 9%-23%, respectively)

  3. The cutaneous lesions of inflammatory bowel disease are classified in the following manner:

    • Specific—These lesions have identical pathologic mechanisms to lesions of the

References (271)

  • J.P. Callen

    Pyoderma gangrenosum

    Lancet

    (1998)
  • J. Reichrath et al.

    treatment recommendations for pyoderma gangrenosu: an evidence-based review of the literature based on more than 350 patients

    J Am Acad Dermatol

    (2005)
  • R.K.P. Chow et al.

    Treatment of pyoderma gangrenosum

    J Am Acad Dermatol

    (1996)
  • E. Ricart et al.

    Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic: the first 100 patients

    Am J Gastroenterol

    (2001)
  • A.E. Werchniak et al.

    Treatment of pyostomatitis vegetans with topical tacrolimus

    J Am Acad Dermatol

    (2005)
  • S.B. Woo et al.

    Recurrent aphthous ulcers: a review of diagnosis and treatment

    J Am Dent Assoc

    (1996)
  • G.O. Solley et al.

    Correlation between regional enteritis and cutaneous polyarteritis nodosa: two cases and review of the literature

    Gastroenterology

    (1975)
  • R.W. Talbot et al.

    Vascular complications of inflammatory bowel disease

    Mayo Clin Proc

    (1986)
  • M. Chen et al.

    The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn’s disease have autoantibodies to type VII collagen

    J Invest Dermatol

    (2002)
  • D.T. Woodley et al.

    Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients

    J Invest Dermatol

    (2006)
  • M. Chen et al.

    NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats

    J Invest Dermatol

    (1999)
  • S. Ahmadi et al.

    Pyoderma gangrenosum: uncommon presentations

    Clin Dermatol

    (2005)
  • J.R. Person et al.

    Autointoxication revisited

    J Am Acad Dermatol

    (1986)
  • J.L. Jorizzo

    Pustular vasculitis: an emerging disease concept

    J Am Acad Dermatol

    (1983)
  • C.H. Dicken

    Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass

    J Am Acad Dermatol

    (1986)
  • S.E. Presser et al.

    Essential fatty acid deficiency after intestinal bypass

    J Am Acad Dermatol

    (1983)
  • S. Gómez-Diez et al.

    Vitamin A deficiency and bowel-associated dermatosis-arthritis syndrome secondary to biliopancreatic diversion for obesity

    Actas Dermosifiliogr

    (2010)
  • A.R. Guerre-Schmidt et al.

    Dermatosis-arthritis syndrome associated with Crohn’s disease in a teenager [in French]

    Rev Med Interne

    (2006)
  • E.V. Loftus et al.

    Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival

    Gut

    (2000)
  • B. Lashner

    Inflammatory bowel disease

  • R.J. Xavier et al.

    Unraveling the pathogenesis of inflammatory bowel disease

    Nature

    (2007)
  • J.C. Barrett et al.

    Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

    Nat Genet

    (2009)
  • J.P. Hugot et al.

    Mapping of a susceptibility locus for Crohn’s disease on chromosome 16

    Nature

    (1996)
  • J.D. Ohmen et al.

    Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn’s disease, but not in ulcerative colitis

    Hum Mol Genet

    (1996)
  • I.J. Fuss et al.

    Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease

    J Immunol

    (1996)
  • A. Ekbom et al.

    Ulcerative colitis and colorectal cancer. A population-based study

    N Engl J Med

    (1990)
  • A.S. Paller

    Cutaneous changes associated with inflammatory bowel disease

    Pediatr Dermatol

    (1986)
  • L. Jiang et al.

    Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central China

    Inflamm Bowel Dis

    (2006)
  • L. Lakatos et al.

    Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25 year follow-up study

    World J Gastroenterol

    (2003)
  • M. Plauth et al.

    Oral manifestations of Crohn’s disease. An analysis of 79 cases

    J Clin Gastroenterol

    (1991)
  • T. Stricker et al.

    Images in clinical medicine. Oral manifestations of Crohn’s disease

    N Engl J Med

    (2000)
  • A.J. Williams et al.

    The clinical entity of orofacial Crohn’s disease

    Q J Med

    (1991)
  • A. Dupuy et al.

    Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases

    Arch Dermatol

    (1999)
  • E.B. Hawryluk et al.

    Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions

    Am J Clin Dermatol

    (2010)
  • G.D. Guest et al.

    Metastatic Crohn’s disease: case report of an unusual variant and review of the literature

    Dis Colon Rectum

    (2000)
  • D. Farhi et al.

    Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients

    Medicine (Baltimore)

    (2008)
  • A.J. Moraes et al.

    Panniculitis in childhood and adolescence

    Pediatr Int

    (2006)
  • A.J. Greenstein et al.

    The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients

    Medicine

    (1976)
  • H.J. Freeman

    Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn’s disease

    Can J Gastroenterol

    (2005)
  • R.S.W. Basler et al.

    Ulcerative colitis and the skin

    Arch Dermatol

    (1976)
  • Cited by (0)

    Funding sources: None.

    Reprints not available from the author.

    View full text